Recent Quotes (30 days)

You have no recent quotes
chg | %

Finance

Show: All - Companies - Funds
Results 1 - 32 of about 17 companies and 15 funds for positive
Company Exchange Symbol Last price Quote change Market cap
Positive Edge Strategies, Inc Private
What PositiveEdge Technologies does is close enough for government work. The company develops and implements technology infrastructures for local, state, ...
S&P 1500 Positive Momentum Tilt Index INDEXSP SP15TLPM 1,919.03 +0.32 (0.02%)
Japan Tobacco Inc TYO 2914 3,674.00 -9.00 (-0.24%) 7.35T
Japan Tobacco Inc. is engaged in the tobacco business. The Company operates in five businesses. The Japan Domestic Tobacco business is engaged in the ...
Positive Electronics Limited BOM 539178 10.58 0.00 (0.00%)
Marsh & McLennan Companies, Inc. NYSE MMC 82.72 +0.38 (0.46%) 42.59B
Marsh & McLennan Companies, Inc. is a professional services firm offering clients advice and solutions in risk, strategy and people. The Company is the parent ...
Nanosphere, Inc. NASDAQ NSPH 0.0000
... Respiratory Pathogens/Expanded Panel (RP Flex); Bloodstream Infection (BSI) Panels, which include Blood Culture – Gram Positive (BC-GP), Blood Culture ...
PositiveID Corp OTCMKTS PSID 0.0160 0.0000 (0.00%) 425,320.00
PositiveID Corporation, formerly VeriChip Corporation, is a life sciences and technology company focused on the healthcare and homeland security markets.
Receptos Inc NASDAQ RCPT 0.0000
Its research efforts include a preclinical program developing oral, small molecule, positive allosteric modulators (PAMs) of the glucagon-like peptide-1 receptor ...
JAPAN TOBACCO INC NPV OTCMKTS JAPAF 32.60 0.00 (0.00%) 65.20B
MARSH & MCLENNAN COS. INC COM US$1 LON MHM 82.12 +2.07 (2.59%)
MARSH+MCLENNAN COS.INC.D1 FRA MSN 67.98 -0.82 (-1.19%)
JAPAN TOBACCO INC UNSP ADR EA REPR ORD OTCMKTS JAPAY 16.37 -0.12 (-0.73%) 65.96B
JAPAN TOBACCO FRA JAT 27.00 -0.38 (-1.37%)
NANOSPHERE INC.NEW DL-,01 FRA 3NSN 1.50 0.00 (0.00%)
RECEPTOS INC. DL-,001 FRA 13R 206.42
MARSH & MCLENNAN CEDEAR EACH 4 REPR 1 USD1 BCBA MMC 0.0000
JAPAN TOBACCO UNSP.ADR1/2 FRA JATA 13.45 -0.21 (-1.54%)
Mutual Fund Symbol Nav Nav change
CITIC-Prudential BRICs Positive Allocation Stock QDII Fund(LOF) 165510 0.85 0.00 (-0.23%)
N/A
Changsheng Positive Asset Allocation Bond Fund CHAN_POSI_ASSE_1DXFKNC 1.08 0.00 (0.01%)
N/A
Dacheng Positive Growth Stock Fund DACH_POSI_GROW_VLF7I9 1.16 -0.01 (-0.68%)
The fund invest in listed companies with good growth potential, avoiding investment risk and seeking to fund long-term property value.
YinHua YongTai Positive Bond Fund C YINH_YONG_POSI_QMUVEV 1.27 0.00 (0.00%)
N/A.
YinHua YongTai Positive Bond Fund A YINH_YONG_POSI_1FBPPXB 1.31 0.00 (0.00%)
N/A.
MinSheng Royal Positive Growth BalanceFund MINS_ROYA_POSI_1MSJPVP 1.34 -0.01 (-0.45%)
NA.
CCB Principal Positive Allocation Balanced Fund CCB_PRIN_POSI_1J6F08S 2.15 0.00 (0.09%)
NA.
Zhonghai Positive Inc Flexible Alloc Fd ZHON_POSI_INC_C52W4X 1.21 0.00 (0.08%)
NA.
Dacheng Positive Return mix DACH_POSI_RETU_K9T68Z 0.76 -0.01 (-0.92%)
在保持资产流动性的基础上,通过有效控制组合下行风险优化组合收益,力争实现 基金资产长期稳定增值。
CaiTong Informtion positive income Bd A CAIT_INFO_POSI_TDLQL8 1.00 0.00 (0.00%)
在有效控制风险的基础上,通过积极主动的投资管理,力争为投资者实现超越业绩 比较基准的投资收益。
CaiTong Informtion positive income Bd C CAIT_INFO_POSI_12R3WB5 1.00 0.00 (0.10%)
在有效控制风险的基础上,通过积极主动的投资管理,力争为投资者实现超越业绩 比较基准的投资收益。
Lion Positive Return Alloc Fd LION_POSI_RETU_GJUZEX 1.02 0.00 (0.00%)
该基金通过灵活的大类资产配置和个股精选,在有效控制风险的前提下,谋求基金 资产的长期增值,力争实现超越业绩比较基准的回报。
Baillie Gifford Positive Change Fund B Income BAIL_GIFF_POSI_ZXM1KL 1.32 -0.01 (-0.53%)
Investment will be primarily in equities of companies whose products or behaviour, in the ACD's opinion, make a positive social impact. This will include ...
Baillie Gifford Positive Change Fund B Accumulation BAIL_GIFF_POSI_YS6MQK 1.32 -0.01 (-0.53%)
Investment will be primarily in equities of companies whose products or behaviour, in the ACD's opinion, make a positive social impact. This will include ...
New China Positive Value Alloc NEW_CHIN_POSI_1XAYKC3 0.93 0.00 (0.32%)
主要投资于价值相对低估且具有良好成长性的中小市值股票,追求基金资产长期稳定 的增值和收益,在合理风险限度内,力争持续实现超越业绩基准的超额收益。